Kamran Hosseini
Currently InSite Vision's chief medical officer, Hosseini will head the company's new scientific advisory board.
He said: "The interest and direct participation of these world-class medical professionals on our SAB reflects the progress InSite is achieving in the development of ocular medicines.
"Our SAB members have already made significant contributions to our current clinical development programs, providing input on trial protocols and endpoint design. We look forward to future contributions in the same vein."